Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

Psychopharmacology (Berl). 1976 Aug 17;48(3):311-8. doi: 10.1007/BF00496868.

Abstract

Norepinephrine (NE) and dopamine (DA) receptor blockade differentially affected amphetamine self-administration. DA blockade (pimozide, 0.0625 to 0.5 mg/kg, or (+)-butaclamol, 0.0125 to 0.1 mg/kg) caused periods of increased rate of responding for amphetamine which were followed, in the case of higher doses, by response cessation. The response cessation produced by 0.5 mg/kg pimozide was not reversed by non-contingent amphetamine injections until well after the peak effect of the pimozide was over. When access to amphetamine injections was delayed until 4 h after animals received 0.5 mg/kg pimozide, rate of responding was elevated. Thus DA seems to be critically involved in mediation of the reinforcing effects of amphetamine. Alpha-NE blockade with phentolamine (2.5-10 mg/kg) produced dose-related decreases in responding; blockade with phenoxybenzamine (1.25-10 mg/kg) had no effect. Beta-NE blockade with l-propranolol (2.5-10 mg/kg) decreased responding, although probably not through a beta-blocking action. The effects of phentolamine and propranolol do not appear to result from attenuation of the reinforcing effects of amphetamine.

MeSH terms

  • Animals
  • Dibenzocycloheptenes / pharmacology
  • Dopamine / physiology*
  • Injections, Intravenous
  • Male
  • Motor Activity / drug effects
  • Phenoxybenzamine / pharmacology
  • Phentolamine / pharmacology
  • Pimozide / pharmacology
  • Propranolol / pharmacology
  • Quinolizines / pharmacology
  • Rats
  • Reinforcement, Psychology

Substances

  • Dibenzocycloheptenes
  • Quinolizines
  • Phenoxybenzamine
  • Pimozide
  • Propranolol
  • Dopamine
  • Phentolamine